ITGAE and lung carcinoma: In lung cancer, the accumulation of CD103+ lymphocytes was reportedly associated with survival benefit through improved T-cell receptor (TCR) antigen sensitivity, leading to rapid T-cell-mediated recognition and higher cytotoxicity against tumor cells [35].